[Intracystic Therapy of Bleomycin for Craniopharyngioma--effect of Bleomycin for Cultured Craniopharyngioma Cells and Intracystic Concentration of Bleomycin (author's Transl)]
Overview
Authors
Affiliations
Visual outcomes after treatment of craniopharyngioma in children: A systematic review.
Colliander R, Sharma S, Shlobin N, Fernandez L, LoPresti M, Lam S Childs Nerv Syst. 2024; 40(6):1641-1659.
PMID: 38416204 DOI: 10.1007/s00381-024-06328-5.
Adamantinomatous craniopharyngioma: evolution in the management.
Massimi L, Palombi D, Musarra A, Bianchi F, Frassanito P, Tamburrini G Childs Nerv Syst. 2023; 39(10):2613-2632.
PMID: 37728836 PMC: 10613147. DOI: 10.1007/s00381-023-06143-4.
Treatment of Cystic Craniopharyngiomas: An Update.
Bianchi F, Benato A, Massimi L Adv Tech Stand Neurosurg. 2022; 45:139-176.
PMID: 35976449 DOI: 10.1007/978-3-030-99166-1_4.
Intracystic bleomycin for cystic craniopharyngiomas in children.
Zhang S, Fang Y, Cai B, Xu J, You C Cochrane Database Syst Rev. 2016; 7:CD008890.
PMID: 27416004 PMC: 6457977. DOI: 10.1002/14651858.CD008890.pub4.
Intracystic therapies for cystic craniopharyngioma in childhood.
Bartels U, Laperriere N, Bouffet E, Drake J Front Endocrinol (Lausanne). 2012; 3:39.
PMID: 22654864 PMC: 3356106. DOI: 10.3389/fendo.2012.00039.